WASHINGTON, April 26 - Under proposed new legislation, the U.S. Food and Drug Administration would gain greater authority over pharmacies that compound sterile drugs for tailored use and ship them across state lines.
The bipartisan proposal comes in the wake of a deadly meningitis outbreak linked to a tainted steroid that killed 53 people and sickened more than 700. The steroid was distributed by the Framingham, Massachusetts-based New England Compounding Center.
(Reporting By Toni Clarke in Washington; Editing by Gerald E. McCormick) Keywords: MENINGITIS LEGISLATION/
(email@example.com)(202-898-8340)(Reuters Messaging: firstname.lastname@example.org)
Copyright Thomson Reuters 2013. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.